US2020332261A1PendingUtilityA1
Native wharton's jelly stem cells and their purification
Est. expiryJun 1, 2030(~3.9 yrs left)· nominal 20-yr term from priority
Inventors:Rouzbeh R. Taghizadeh
A61L 27/3834C12N 5/0668C12N 5/06C12N 2502/025A61K 35/51C12N 5/0605C12N 5/0662C12N 5/0602C12N 5/00C12N 5/0037C12N 2500/84
72
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Noncultured Wharton's Jelly stem cells and methods of their purification, storage and use are provided.
Claims
exact text as granted — not AI-modifiedWe claim:
1 .- 30 . (canceled)
31 . A method of freezing a composition comprising a Wharton's Jelly filtrate, the method comprising:
preparing a cell-depleted Wharton's Jelly filtrate by (a) mincing umbilical cord tissue comprising Wharton's Jelly, (b) subsequently diluting the umbilical cord tissue with a buffer and optionally a salt solution in an amount sufficient to reduce viscosity, (c) subsequently filtering the umbilical cord tissue to generate a homogenous filtrate, (d) sedimenting Wharton's Jelly stem cells from the filtrate to generate the homogenous cell-depleted Wharton's Jelly filtrate, and freezing the Wharton's Jelly filtrate at or below −20 ° C.
32 . The method of claim 31 , wherein the Wharton's Jelly filtrate is frozen at a temperature at or below −80 ° C.
33 . The method of claim 31 , wherein the Wharton's Jelly filtrate is frozen at a temperature at or below −180 ° C.
34 . The method of claim 31 , wherein prior to mincing the umbilical cord tissue, an antibiotic is added to the umbilical cord tissue.
35 . The method of claim 31 , wherein the method comprises exposing the umbilical cord tissue to a protease.
36 . The method of claim 31 , wherein the salt solution comprises Dulbecco's phosphate buffered saline.
37 . The method of claim 31 , wherein the homogenous cell-depleted Wharton's Jelly filtrate is completely devoid of cells.
38 . The cell culture medium of claim 31 , wherein the umbilical cord tissue includes arteries and veins.
39 . A method of freezing cells at or below −20 ° C., the method comprising:
freezing purified cells in a Wharton's jelly filtrate at or below −20 ° C.
40 . The method of claim 39 , wherein the Wharton's Jelly filtrate is frozen at a temperature at or below −80 ° C.
41 . The method of claim 39 , wherein the Wharton's Jelly filtrate is frozen at a temperature at or below −180 ° C.
42 . The method of claim 39 , wherein the Wharton's Jelly has been digested using mechanical digestion.
43 . The method of claim 39 , wherein the Wharton's Jelly has been digested using enzymatic digestion.
44 . The method of claim 39 , wherein the Wharton's jelly filtrate is prepared by mincing umbilical cord tissue comprising Wharton's Jelly, subsequently diluting the umbilical cord tissue with a buffer, and subsequently filtering the umbilical cord tissue to generate a homogenous Wharton's jelly filtrate.
45 . The method of claim 44 , wherein the buffer is present in an amount sufficient to reduce viscosity of the Wharton's Jelly filtrate.
46 . The method of claim 44 , wherein the method further comprises the step of sedimenting Wharton's Jelly stem cells from the filtrate to generate a cell-depleted Wharton's Jelly filtrate.
47 . The method of claim 39 , further comprising the step of culturing the cells.
48 . The method of claim 39 , wherein the cells comprise cells of a cell type other than Wharton's Jelly stem cells.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.